A01=David S. Stephens
A01=Kathryn M. Edwards
A01=Walter A. Orenstein
Author_David S. Stephens
Author_Kathryn M. Edwards
Author_Walter A. Orenstein
book on covid vaccine
Category=VFJB
Coronavirus
coronavirus prepping
coronavirus survival
coronavirus symptoms
coronavirus testing
coronavirus vaccine
COVID masks
covid vaccine
covid vaccine book
covid vaccine safety
covid vaccine side effects
eq_bestseller
eq_health-lifestyle
eq_isMigrated=0
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
masking
masks
MERS
moderna vaccine
mrna
mrna science
pandemic
pfizer vaccine
SARS
vaccine safety
vaccine timelines
Product details
- ISBN 9781510767225
- Weight: 170g
- Dimensions: 152 x 229mm
- Publication Date: 10 Jun 2021
- Publisher: Skyhorse Publishing
- Publication City/Country: US
- Product Form: Paperback
Secure
checkout
Fast Shipping
Easy returns
What you should know about the Covid-19 vaccines from top experts in the field.
As the SARS-Cov2 virus emerged and spread globally in early 2020, unprecedented international efforts began to develop and test vaccines to control the devastating pandemic. This book focuses on the remarkable progress in developing vaccines, the amazing effectiveness of the early vaccines, and the challenges of delivering them to the population. To put this extraordinary progress into perspective, the history of other vaccines is presented and their roles in individual protection and protection of the community, “vaccines that protect the unvaccinated,” are outlined.
The rigorous processes whereby vaccines are evaluated in distinct phases and the steps that must be met prior to obtaining regulatory approval for both vaccine safety and effectiveness are highlighted. Multiple vaccine approaches are reviewed, including new approaches such as “messenger or mRNA vaccine” that may revolutionize future vaccine development. The comprehensive models used to provide recommendations and priorities for vaccination of groups of people at risk are summarized. The book also focuses on the questions that remain unanswered after the vaccines are approved. These include duration of immunity, risk factors for vaccine failure, impact of viral evolution and variant strains, and assessment of both immediate and long-term safety. The authors also address concerns about vaccine acceptance including roll-out, access, and detailed and trusted sources of information.
As the SARS-Cov2 virus emerged and spread globally in early 2020, unprecedented international efforts began to develop and test vaccines to control the devastating pandemic. This book focuses on the remarkable progress in developing vaccines, the amazing effectiveness of the early vaccines, and the challenges of delivering them to the population. To put this extraordinary progress into perspective, the history of other vaccines is presented and their roles in individual protection and protection of the community, “vaccines that protect the unvaccinated,” are outlined.
The rigorous processes whereby vaccines are evaluated in distinct phases and the steps that must be met prior to obtaining regulatory approval for both vaccine safety and effectiveness are highlighted. Multiple vaccine approaches are reviewed, including new approaches such as “messenger or mRNA vaccine” that may revolutionize future vaccine development. The comprehensive models used to provide recommendations and priorities for vaccination of groups of people at risk are summarized. The book also focuses on the questions that remain unanswered after the vaccines are approved. These include duration of immunity, risk factors for vaccine failure, impact of viral evolution and variant strains, and assessment of both immediate and long-term safety. The authors also address concerns about vaccine acceptance including roll-out, access, and detailed and trusted sources of information.
Kathryn M. Edwards, MD, the Sarah H. Sell and Cornelius Vanderbilt Professor of Pediatrics at Vanderbilt, has conducted pivotal trials of vaccines licensed in the past several decades and has led the CDC-funded Center for Immunization Safety Assessment (CISA) site. She has served on many CDC, NIH, FDA, WHO, and IDSA committees.
Walter A. Orenstein, MD, DSc (Hon), is a Professor of Medicine, Epidemiology, Global Health, and Pediatrics at Emory University. From 2008 through 2011, he was Deputy Director for Immunization Programs at the Bill & Melinda Gates Foundation. From 1988-2004, he was the Director of the United States Immunization Program. He is a former Assistant Surgeon General of the USPHS.
David S. Stephens, MD, is the Stephen W. Schwarzmann Distinguished Professor of Medicine and Professor of Microbiology and Immunology and Epidemiology at Emory University. He is Vice-President for Research of Emory’s Robert W. Woodruff Health Sciences Center and is Chair of the Department of Medicine in the School of Medicine.
Walter A. Orenstein, MD, DSc (Hon), is a Professor of Medicine, Epidemiology, Global Health, and Pediatrics at Emory University. From 2008 through 2011, he was Deputy Director for Immunization Programs at the Bill & Melinda Gates Foundation. From 1988-2004, he was the Director of the United States Immunization Program. He is a former Assistant Surgeon General of the USPHS.
David S. Stephens, MD, is the Stephen W. Schwarzmann Distinguished Professor of Medicine and Professor of Microbiology and Immunology and Epidemiology at Emory University. He is Vice-President for Research of Emory’s Robert W. Woodruff Health Sciences Center and is Chair of the Department of Medicine in the School of Medicine.
